CAPTIM

CAPTIM

Myocarde, or Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction (Comparaison de l’Angioplastie Primaire et de la Thrombolyse pre-hospitalière à la phase aiguë de l’Infarctus du Myocarde). An underpowered clinical trial which compared the efficacy of pre-hospital thrombolysis with primary percutaneous coronary intervention (PCI) for acute ST elevation MI.
 
Primary endpoints
Adverse event composite—death, nonfatal reinfarction, stroke.
 
Conclusion
No differences between prehospital thrombolysis and primary PCI; event rate was 8.2% for prehospital thrombolysis and 6.2% for primary angioplasty; mortality was 3.8% in the prehospital thrombolysis and 4.8% for primary angioplasty; slow enrollment resulted in early termination
References in periodicals archive ?
In CAPTIM study (8), AMI patients with ST elevation were demonstrated to have an inconsiderable decrease in adverse cases in the PTCA group (6.
Soz konusu calismalardan farkli olarak uygulama zamani acisindan hastane oncesi trombolitik tedavi ile primer anjiyoplasti, CAPTIM (Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction) calismasinda karsilastirildi (23).